Pharm Exam 2 Flashcards

1
Q

What are the indications for ACE inhibitors?

A

Hypertension (HTN), Heart failure with reduced ejection fraction (HFrEF), Post-myocardial infarction (MI) to reduce mortality, Chronic kidney disease (CKD) with proteinuria, Diabetic nephropathy

These conditions are treated with ACE inhibitors to improve patient outcomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the contraindications for ACE inhibitors?

A

Pregnancy, History of angioedema, Bilateral renal artery stenosis, Hyperkalemia, Severe hypotension

These contraindications are crucial to avoid serious adverse effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the mechanism of action (MOA) of Calcium Channel Blockers (CCBs)?

A

CCBs block L-type calcium channels, reducing calcium influx into vascular smooth muscle and cardiac myocytes, leading to vasodilation, decreased myocardial contractility, and reduced conduction velocity in the heart

This action helps in managing hypertension and other cardiovascular conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the adverse drug effects (ADEs) of dihydropyridine CCBs?

A

Reflex tachycardia, Peripheral edema, Flushing, Dizziness, headache

These effects are common with dihydropyridine CCBs like amlodipine and nifedipine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the adverse drug effects (ADEs) of non-dihydropyridine CCBs?

A

Bradycardia, AV block, Worsening heart failure, Constipation

Non-dihydropyridines such as verapamil and diltiazem have these specific ADEs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fill in the blank: Non-dihydropyridine CCBs primarily act on the _______ while dihydropyridine CCBs act on _______.

A

Heart; Vascular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the first-line treatment options for hypertension in non-Black patients?

A

ACE inhibitors or ARBs, Thiazide diuretics, CCBs

These medications are recommended for managing hypertension effectively.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the role of the Renin-Angiotensin-Aldosterone System (RAAS) in hypertension?

A

RAAS causes vasoconstriction, stimulates aldosterone release (increases Na⁺ & water retention), and enhances sympathetic activity, leading to increased blood pressure

Chronic activation of RAAS contributes to hypertension and heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the selective beta-blockers.

A

Metoprolol, Atenolol, Nebivolol, Bisoprolol, Acebutolol, Betaxolol, Esmolol

These agents are primarily used for conditions like hypertension and heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the first-line agents indicated in the treatment of heart failure (HF)?

A

ACE Inhibitors / ARBs, Beta-Blockers, Mineralocorticoid Receptor Antagonists (MRAs), ARNI

These medications improve mortality and morbidity in patients with HF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the contraindications of non-dihydropyridine CCBs in heart failure?

A

HFrEF, Severe hypotension

Non-dihydropyridine CCBs are contraindicated due to their negative inotropic effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the adverse effects of loop diuretics?

A

Hypokalemia, Hypomagnesemia, Ototoxicity, Hypovolemia

Loop diuretics like furosemide are potent but have significant side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What monitoring is recommended for patients on ACE inhibitors?

A

Monitor BP, serum creatinine, potassium

Regular monitoring helps prevent complications from these medications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the mechanism of action of statins?

A

Inhibit HMG-CoA reductase, decreasing LDL-C production and increasing LDL receptor expression

This action is crucial for managing cholesterol levels and reducing cardiovascular risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the adverse effects of statins?

A

Myopathy, Rhabdomyolysis, Hepatotoxicity, New-onset diabetes, GI disturbances, Cognitive impairment

Awareness of these ADEs is important for patient safety.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fill in the blank: Ezetimibe primarily lowers _______ levels.

A

LDL-C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What differentiates unfractionated heparin (UFH) from low molecular weight heparin (LMWH)?

A

UFH inactivates Factor IIa and Xa; LMWH primarily inactivates Factor Xa

This difference impacts their clinical use and monitoring requirements.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What factors does UFH primarily inactivate?

A

Factor IIa (Thrombin) & Factor Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the onset of action for SubQ administration of LMWH?

A

20-30 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What type of monitoring is required for UFH?

A

aPTT required (dose-dependent effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Which reversal agent provides full reversal for UFH?

A

Protamine sulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is LMWH typically dosed?

A

Fixed SubQ dosing once or twice daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the half-life of UFH?

A

Short (~1.5 hours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the clinical uses of LMWH?

A
  • DVT
  • PE
  • ACS
  • VTE prophylaxis in surgery
  • Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is a common adverse effect of UFH?

A

Heparin-Induced Thrombocytopenia (HIT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the contraindications for Heparin / LMWH?

A
  • Active bleeding
  • HIT
  • Severe thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the mechanism of action of Heparins?

A

Enhances Antithrombin III (ATIII) → Inhibits Factor Xa & IIa (thrombin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Which class of drugs does Warfarin belong to?

A

Vitamin K Antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is a key clinical use of Direct Oral Anticoagulants (DOACs)?

A

Stroke prevention in AFib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the mechanism of action of aspirin?

A

Irreversibly inhibits cyclooxygenase-1 (COX-1) → ↓ Thromboxane A2 (TXA2) → ↓ platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the effect of Class I antiarrhythmics on action potential?

A

Slow depolarization (Phase 0)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is the half-life of Amiodarone?

A

15–100 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is the primary target for Class II antiarrhythmics?

A

β-blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What is a common adverse effect of Metformin?

A

Gastrointestinal (GI) distress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What is the primary mechanism of action of SGLT2 inhibitors?

A

Inhibits sodium-glucose cotransporter 2 (SGLT2) in the proximal renal tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Which supplement is indicated for pernicious anemia?

A

Vitamin B12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is a risk associated with intravenous iron administration?

A

Anaphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is the role of nitrates in stable angina management?

A

↓ Myocardial O₂ demand by reducing preload

39
Q

What is the mechanism of action of DPP-4 inhibitors?

A

Inhibit dipeptidyl peptidase-4 (DPP-4), enhancing endogenous incretin activity

40
Q

Which drug class is known for causing weight loss in T2DM patients?

A

GLP-1 Receptor Agonists

41
Q

What should be monitored for Vitamin B12 supplementation?

A

Serum B12 levels, MMA, homocysteine levels

42
Q

Fill in the blank: The half-life of Esmolol is _______.

43
Q

True or False: Long-acting nitrates do not require a nitrate-free interval.

44
Q

What is a common adverse effect of iron supplementation?

A

GI distress, constipation

45
Q

What is the mechanism of action of Class III antiarrhythmics?

A

K⁺ channel blockade → Prolongs AP duration & QT interval

46
Q

What is the clinical use of short-acting nitrates?

A

Acute angina attacks, prophylaxis before exertion

47
Q

What do DPP-4 inhibitors degrade?

A

GLP-1 and GIP

48
Q

What do DPP-4 inhibitors enhance?

A

Endogenous incretin activity, increasing insulin secretion and reducing glucagon levels

49
Q

What is the clinical use of DPP-4 inhibitors?

A

Used as a second-line therapy for patients who cannot tolerate metformin or need an additional agent

50
Q

What is the weight effect of DPP-4 inhibitors?

A

Weight neutral (neither causes weight gain nor weight loss)

51
Q

What is the hypoglycemia risk of DPP-4 inhibitors compared to sulfonylureas?

A

Lower hypoglycemia risk than sulfonylureas

52
Q

What is a significant advantage of DPP-4 inhibitors over GLP-1 receptor agonists?

A

Oral formulation, making it more convenient than GLP-1 receptor agonists (which are injectable)

53
Q

What is the renal safety profile of linagliptin?

A

Safe in renal impairment (linagliptin does not require dose adjustment)

54
Q

What is the mechanism of action of thiazolidinediones (TZDs)?

A

Activate peroxisome proliferator-activated receptor gamma (PPAR-γ) in adipose tissue, skeletal muscle, and liver

55
Q

What do TZDs increase in the body?

A

Insulin sensitivity, improving glucose uptake and reducing hepatic glucose production

56
Q

What are TZDs used for in diabetes management?

A

Alternative to metformin in patients with significant insulin resistance

57
Q

What cardiovascular benefit does pioglitazone provide?

A

Reduces stroke risk in patients with diabetes

58
Q

What are the contraindications for TZDs?

A
  • Heart failure (NYHA Class III or IV) due to fluid retention risk
  • History of bladder cancer (pioglitazone may increase bladder cancer risk)
  • Active liver disease due to potential hepatotoxicity
59
Q

What is a common adverse effect of TZDs?

A

Weight gain due to fluid retention and fat accumulation

60
Q

What is a key consideration when choosing diabetes medications?

A

Match drug class with patient profile and contraindications

61
Q

What is the role of basal insulin?

A

Provides steady insulin levels throughout the day to control fasting glucose

62
Q

What is the primary use of mealtime insulin?

A

Taken before meals to cover the postprandial rise in blood glucose

63
Q

What types of insulin are classified as rapid-acting?

A
  • Lispro
  • Aspart
  • Glulisine
64
Q

What is the onset time for rapid-acting insulin?

A

10-30 minutes

65
Q

What is the duration of action for short-acting insulin?

66
Q

What is the primary characteristic of long-acting insulin?

A

Provides steady glucose control with duration of over 24 hours

67
Q

Which insulins can be mixed with NPH?

A
  • Rapid-acting insulins (lispro, aspart)
  • Short-acting insulin (regular insulin)
68
Q

What should never be mixed with long-acting insulins?

A

Other insulins (e.g., glargine, detemir, degludec)

69
Q

What is the most common adverse effect of insulin?

A

Hypoglycemia

70
Q

What is lipodystrophy?

A

Injection site changes due to repeated injections in the same spot

71
Q

What are the effects of glucocorticoids on glucose metabolism?

A

Increase gluconeogenesis in the liver, contributing to hyperglycemia

72
Q

What is the preferred therapy for hypothyroidism?

A

Levothyroxine (T4)

73
Q

What is the half-life of levothyroxine?

A

Approximately 7 days

74
Q

What are the main antithyroid medications for hyperthyroidism?

A
  • Methimazole (MMI)
  • Propylthiouracil (PTU)
75
Q

What is the mechanism of action of Methimazole?

A

Inhibits thyroid peroxidase (TPO) to prevent T4/T3 synthesis

76
Q

What adverse effect is associated with both Methimazole and PTU?

A

Agranulocytosis

77
Q

What is the risk associated with rapid discontinuation of glucocorticoids?

A

Acute adrenal insufficiency

78
Q

What is a characteristic effect of glucocorticoids on bone health?

A

Inhibits osteoblast activity, leading to osteoporosis

79
Q

What is important about tapering glucocorticoids?

A

Required to allow adrenal recovery after long-term use

80
Q

What is the role of progestin in hormonal contraceptives?

A

Suppresses ovulation by inhibiting luteinizing hormone (LH) secretion

81
Q

What is the role of progestin in hormonal contraceptives?

A

Progestin suppresses ovulation, thickens cervical mucus, alters the endometrium, and reduces tubal motility.

Progestin is a synthetic form of progesterone.

82
Q

What are the types of progestin-containing contraceptives?

A
  • Progestin-Only Pills (POPs)
  • Injectable Progestins (e.g., Depo-Provera)
  • Implant (e.g., Nexplanon)
  • Intrauterine Devices (IUDs)
  • Emergency Contraception (EC)

Each type has unique characteristics and effectiveness.

83
Q

What is a key characteristic of Progestin-Only Pills (POPs)?

A

Must be taken at the same time daily due to a shorter half-life.

Less effective at suppressing ovulation compared to combination pills.

84
Q

What is the duration of effectiveness for Injectable Progestins like Depo-Provera?

A

Provides contraception for 3 months per injection.

Can cause delayed return to fertility after discontinuation.

85
Q

What is a major risk associated with estrogen in contraceptives?

A

Increased risk of venous thromboembolism (VTE).

This includes deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke.

86
Q

Which women are at highest risk for VTE when using estrogen-containing contraceptives?

A

Smokers, obese individuals (BMI ≥30), and those over 35 years old.

Transdermal patches may have a higher VTE risk than oral contraceptives.

87
Q

What are absolute contraindications to estrogen-containing contraceptives?

A
  • History of thromboembolic disease
  • Migraine with aura
  • Uncontrolled hypertension
  • Smoking in women over 35
  • Current or history of breast cancer
  • Severe liver disease

These contraindications are outlined by the U.S. Medical Eligibility Criteria (MEC).

88
Q

What are contraindications for progestin-only contraceptives?

A
  • Active liver disease
  • History of breast cancer
  • Undiagnosed abnormal vaginal bleeding

Requires further evaluation for abnormal vaginal bleeding.

89
Q

True or False: Progestin-only methods carry higher cardiovascular risks than estrogen-containing methods.

A

False.

Progestin-only methods have fewer cardiovascular risks.

90
Q

What changes does progestin induce in the endometrium?

A

Makes it less suitable for implantation.

This is part of its role in preventing pregnancy.

91
Q

What is the effectiveness duration of Levonorgestrel-releasing IUDs?

A

Provides contraception for 3–7 years.

It also reduces menstrual bleeding and cramps.

92
Q

What is the effectiveness window for Levonorgestrel (Plan B One-Step) as emergency contraception?

A

Effective within 72 hours post-intercourse.

Ulipristal acetate (Ella) is effective up to 5 days post-intercourse.

93
Q

What is a potential complication of long-term use of hormonal contraceptives?

A

Higher risk of complications requiring careful monitoring.

This includes issues like osteoporosis prevention and glucose monitoring.

94
Q

In critical illness or stress, what may be required for patients on hormonal contraceptives?

A

Stress dosing to prevent adrenal crisis.

This is particularly important in acute situations.